Use access key #2 to skip to page content.
$13.68 0.27 (2.01%)
10/13/2008 4:04 PM

Emergent BioSolutions, Inc. (EBS)

CAPS Rating:
****

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

View All Commentary (EBS)

Recs

0

Avatar jamasony2 (51.05) Submitted: 7/14/08 3:13 PM : Outperform Start Price: $12.25 EBS Score: 30.28

Buy on retracement to 50 day MA

Report this Post Replies: 0 | Reply

Featured Broker Partners